Real-time enrollment status for this brain tumor clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 12:08 PM UTC
| NCT Number | NCT06413706 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Brain tumor |
| Phase | Clinical Trial |
| Target Enrollment | 45 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | February 19, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT06413706 is currently active_not_recruiting participants. This clinical trial study for brain tumor is not currently accepting new participants at 20 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06413706 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06413706 was last updated 1 week ago (February 19, 2026). HelloStudys verifies this status automatically.